| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/08/2004 | WO2004005339A3 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/08/2004 | WO2004003006A3 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 04/08/2004 | WO2003097055A3 Inhibitors of resistance to bacteria antibiotics |
| 04/08/2004 | WO2003095482A3 Novel cyclic peptides and use thereof as anti-microbial agents |
| 04/08/2004 | WO2003092633A3 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003092600A3 Site specific listeria integration vectors and methods for using the same |
| 04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
| 04/08/2004 | WO2003087121A8 Branched polyamine steroid derivatives |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003024223A8 Pesticidal formulations |
| 04/08/2004 | WO2003022209A9 Crystalline forms of valacyclovir hydrochloride |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068108 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type |
| 04/08/2004 | US20040068094 Ring modified cyclic peptide analogs |
| 04/08/2004 | US20040068039 PVA embolic materials are prepared through saponifying poly(vinyl pivalate) |
| 04/08/2004 | US20040067998 Oral administering |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
| 04/08/2004 | US20040067977 Tropane derivatives useful in therapy |
| 04/08/2004 | US20040067975 Amido ether substituted imidazoquinolines |
| 04/08/2004 | US20040067965 Viricides; cytomegalo virus |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067947 Atherosclerosis; restenosis; cardiovascular disorders; immunosuppresants |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/08/2004 | US20040067925 Multilayer tablet containing amyoxycillin, or sodium salt thereof |
| 04/08/2004 | US20040067912 Microbiocides, antibiotic, antitumor agent |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067899 Administering glycyrrhizin, or salt thereof |
| 04/08/2004 | US20040067879 Effective against fungi such as Candida parapsilosis, Candida albicans, Cryptococcus neoformans, and/or Histoplasma capsulatum |
| 04/08/2004 | US20040067878 Novel lipopeptides as antibacterial agents |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067517 Of given amino acid sequence; binds with antibodies to the causative agent; expressed by spirochetes of Borrelia burgdorferi |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067253 Pharmaceutical preparation, method for its production as well as its use |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | CA2500218A1 Drug absorptivity improving agent |
| 04/08/2004 | CA2500158A1 Bifunctional heterocyclic compounds and methods of making and using same |
| 04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | CA2498787A1 Antibody for adcc and inducing cytokine production |
| 04/08/2004 | CA2498383A1 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2497333A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 04/08/2004 | CA2495338A1 Pyrazole amides for treating hiv infections |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405855A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 04/07/2004 | EP1405643A1 Acellular pertussis vaccines and methods of preparation thereof |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404853A1 Process for the production of allicin |
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404817A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404694A1 Nucleoside compounds in hcv |
| 04/07/2004 | EP1404693A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| 04/07/2004 | EP1404678A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404666A1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404657A1 Pyridazinone |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404644A2 Novel hydrazones |
| 04/07/2004 | EP1404367A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404347A2 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |